# A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine

> **NCT07674654** · PHASE3 · RECRUITING · sponsor: **Kallyope Inc.** · enrollment: 1000 (estimated)

## Conditions studied

- Acute Migraine

## Interventions

- **DRUG:** Elismetrep
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07674654
- **Lead sponsor:** Kallyope Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08-03
- **Primary completion:** 2028-06
- **Final completion:** 2028-06
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2026-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07674654

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07674654, "A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07674654. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*